Suggestions
Liam Eves
Accelerating Clinical Trials | Builder of Clinical Trial Companies | Advisor | Speaker
Professional Background
Liam Eves is a distinguished professional with an impressive track record in the clinical trials industry, characterized by extensive experience in building and growing clinical trial businesses. He has an outstanding ability to raise capital, having successfully raised over £100 million and floated a company on AIM. Liam's career is marked by operational growth, program management, and process (re)engineering across both established and new business units. Throughout his career, he has demonstrated exceptional commercial and operational expertise, particularly in scaling operations to meet the demands of an evolving industry.
Liam has been instrumental in leading major clinical trial deliverables, which encompass every aspect of the process from project management to patient recruitment and experience, clinical operations, data management, laboratories, and medical and scientific leadership. His expertise extends to business analytics, providing insights that drive organizational success. Moreover, Liam has held several C-suite and advisory positions in diverse settings, including remote monitoring and decentralized trial companies as well as MedTech organizations.
Education and Achievements
Liam's educational journey includes a Bachelor of Science with Honors in Neuropsychology from the University of Central Lancashire, where he developed a robust understanding of the intersection between psychology and neuroscience—skills that are valuable in clinical trial design and patient interaction. Additionally, he has further enriched his expertise by studying Artificial Intelligence Product Management at Udacity, positioning himself at the cutting edge of technology application in clinical trials and healthcare.
His commitment to improving clinical trial delivery established him as a thought leader in the field. Through his role as the Executive Clinical Trial Consultant at h-BAR Consultants Ltd, he provided valuable insights that propelled organizations to enhance their operational models. Notably, his time as Executive Vice President of Operations and Chief Operating Officer at hVIVO saw him overseeing significant advancements in patient experience and data management, transforming clinical trial methodologies to be more efficient and patient-centric.
Notable Positions and Contributions
Liam's leadership at hVIVO is particularly noteworthy, where his roles spanned across various facets of clinical operations. Starting as Head of Volunteer Screening Services and progressing through various leadership roles at the company, he garnered extensive experience in patient recruitment and project management. His work contributed to improving patient engagement and streamlining recruitment processes, which are essential components of successful clinical trials.
His entrepreneurial spirit shone during his time as Co-Founder of epro Consultancy, where he harnessed his knowledge to assist other organizations in enhancing their clinical trial strategies. In addition, his early career as a professional football player for Burnley Football Club shaped his tenacity, discipline, and teamwork abilities, which have undoubtedly influenced his professional accomplishments.
Achievements
Liam Eves has a well-documented history of driving business growth through strategic planning and successful fundraising initiatives. His persistence and strategic mindset have led to considerable achievements in mergers and acquisitions (M&A) and initial public offerings (IPOs), further establishing him as a formidable figure in the clinical trial space. Liam's multifaceted capabilities—ranging from fundraising to consulting—underscore his adaptability and keen insights into the intersections of healthcare and business.
As a former site manager and marketing manager at MAC Clinical Research, Liam cultivated skills in patient recruitment and project management that are vital to today’s clinical trial landscape. He actively seeks to improve patient experiences through innovative strategies and by understanding the complexities of patients’ needs.
In summary, Liam Eves exemplifies a unique blend of clinical, operational, and business acumen that has positioned him as a leader in the clinical trial industry. His educational background paired with his extensive professional experiences creates a narrative of success that inspires others in the field. Liam continues to leverage his expertise in clinical trial delivery and strategic growth, driving the future of healthcare with a strong focus on patient engagement and operational excellence.
Highlights
Downstream consequences of protocol development in clinical trials.
When developing clinical trial protocols, we often think of the process as linear, guided strictly by science and logic.
A bunch of super-smart scientists and clinicians gather in a boardroom, armed with data and a pile of best practices.
They whip up a plan that’s airtight, right?
But here’s the thing: these people aren’t the ones who will actually deliver the study.
They’re not the ones interacting with patients or dealing with the messy, unpredictable world where the rubber meets the road.
𝗪𝗵𝗮𝘁 𝘀𝗼𝘂𝗻𝗱𝘀 𝘁𝗿𝗶𝘃𝗶𝗮𝗹 𝗼𝗻 𝗽𝗮𝗽𝗲𝗿 𝗰𝗮𝗻 𝗯𝗲𝗰𝗼𝗺𝗲 𝗮 𝗻𝗶𝗴𝗵𝘁𝗺𝗮𝗿𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗿𝗲𝗮𝗹 𝘄𝗼𝗿𝗹𝗱.
I learned this when I was leading a CRO/Site business, conducting our own clinical trials.
I sat down with the protocol designers and dropped a bombshell: I told them exactly how much each of their decisions would cost us in terms of time and resources.
And guess what? They started cutting down the protocol requirements.
They weren’t trying to sabotage the study—they just didn’t realize how much their decisions could mess up the timeline. A few small tweaks, and suddenly, we were on track to deliver ahead of schedule.
𝗧𝗵𝗲 𝗙𝗮𝗰𝘁𝗼𝗿𝘆 𝗔𝗻𝗮𝗹𝗼𝗴𝘆 Picture this: A factory sitting on the edge of a river.
Back in the day, factories would just dump their waste into the river without a second thought. But then someone had a brilliant idea: what if the factory had to draw its water downstream from its own waste outlet? Suddenly, the factory was forced to deal with the consequences of its own pollution.
This is exactly what needs to happen with clinical trial protocols. Protocol designers need to think downstream—to the real-world impact of their decisions. But for that to happen, you’ve got to have
- the right people in the room from the get-go
- an understanding of the impact of your decisions.
𝗛𝗶𝗻𝗱𝘀𝗶𝗴𝗵𝘁 𝗶𝘀 𝟮𝟬/𝟮𝟬, 𝗕𝘂𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁 𝗶𝘀 𝗘𝘃𝗲𝗻 𝗕𝗲𝘁𝘁𝗲𝗿 It’s great to see that more teams are involving patients in the design of trials, but let’s not kid ourselves—this is far from standard practice.
We need patients, sites and clinical trial operators in the boardroom, telling us what really matters to them. Their experience, knowledge and insights would be foolish to ignore.
𝗔 𝗙𝗶𝗻𝗮𝗹 𝗧𝗵𝗼𝘂𝗴𝗵𝘁 Getting the right people and data in the room early on can turn minor protocol tweaks into major timeline / delivery victories.
🤔 So, how do we align everyone involved to ensure the trial is a success? Share your thoughts below.
P.S. Follow 🔔 Liam Eves for more info on clinical trial delivery.
𝗔 𝗙𝗶𝗻𝗮𝗹 𝗧𝗵𝗼𝘂𝗴𝗵𝘁
Early conversations with the right people turn small protocol tweaks into major timeline triumphs.
🤔 Is there a way to align all stakeholders in the process to the successful delivery of the trial? Please comment below.
Sandy Robbins joins Liam on this week’s clinical trial podcast episode.
Sandy is the Vice President of Commercial Operations at MMS.
Sandy has built an impressive career focused on strategic pricing across several prominent companies, including Syneos, PPD, Quintiles, and more.
In our discussion today, we delve into a range of critical topics, including the distinction between price and value in the industry, what’s broken in the current trial model between sponsors, CROs, and sites, and why we shouldn’t rely on past pricing models to shape the future. Additionally, we explore Sandy's backstory on how she entered the clinical trials space, her unique process for helping groups demonstrate value over price, and much more.
See the link in the comments for the podcast episode.
You can also listen to it on all the good podcast platforms such as Spotify.
Follow 🔔 Liam Eves for more.
